Biovie Inc (BIVI)

NASDAQ
Currency in USD
1.1400
-0.0500(-4.20%)
Closed·
After Hours
1.1201-0.0199(-1.7456%)
·
BIVI Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
BIVI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.12001.1900
52 wk Range
0.62007.5000
Key Statistics
Edit
Prev. Close
1.14
Open
1.19
Day's Range
1.12-1.19
52 wk Range
0.62-7.5
Volume
150.03K
Average Vol. (3m)
416.5K
1-Year Change
-75.22%
Book Value / Share
1.18
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIVI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.0000
Upside
+426.32%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Biovie Inc News & Analysis

Show more

Biovie Inc Company Profile

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company develops BIV201 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer’s disease; and in Phase 2 clinical trial to treat Parkinson’s disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Compare BIVI to Peers and Sector

Metrics to compare
BIVI
Peers
Sector
Relationship
P/E Ratio
−1.1x−4.7x−0.5x
PEG Ratio
−0.010.010.00
Price / Book
1.0x2.7x2.6x
Price / LTM Sales
-1,881.8x3.1x
Upside (Analyst Target)
-192.3%51.1%
Fair Value Upside
Unlock7.3%8.9%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 6.0000
(+426.32% Upside)

Earnings

Latest Release
Feb 11, 2025
EPS / Forecast
-1.05 / -0.28
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BIVI Income Statement

People Also Watch

2.520
AGMH
-12.50%
1.60
KLTO
-20.00%
1.115
OMEX
-10.08%
2.10
GELS
-8.70%
5.4500
STSS
-7.47%

FAQ

What Is the Biovie (BIVI) Stock Price Today?

The Biovie stock price today is 1.14

What Stock Exchange Does Biovie Trade On?

Biovie is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Biovie?

The stock symbol for Biovie is "BIVI."

What Is the Biovie Market Cap?

As of today, Biovie market cap is 21.13M.

What Is Biovie's Earnings Per Share (TTM)?

The Biovie EPS (TTM) is -1.66.

From a Technical Analysis Perspective, Is BIVI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Biovie Stock Split?

Biovie has split 2 times.

How Many Employees Does Biovie Have?

Biovie has 14 employees.

What is the current trading status of Biovie (BIVI)?

As of Jun 16, 2025, Biovie (BIVI) is trading at a price of 1.14, with a previous close of 1.14. The stock has fluctuated within a day range of 1.12 to 1.19, while its 52-week range spans from 0.62 to 7.50.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.